89
288 576

1:37

Brett Crawford: Art & Science

6:51

Meet Kevin Eggan

Meet Ganesh Vedantham

0:55

Commitment to Patients: Annabelle's Story

At BioMarin, our purpose is to transform lives through genetic discovery as we share inspiring stories of individuals like Annabelle.

Відео

1:37

Commitment to Patients: Kendra's Story

Переглядів 432Рік тому

At BioMarin, our work is inspired by people like Kendra. We’re honored to have played a role in helping her live her dreams.

6:51

Brett Crawford: Art & Science

Переглядів 798Рік тому

Meet Brett Crawford, BioMarin's Head of the Musculoskeletal Therapeutic Area in BioMarin Research.

1:02

Meet Kevin Eggan

Переглядів 652Рік тому

Kevin Eggan, Ph.D., joined BioMarin in October 2020 and serves as Group Vice President, Head of Research and Early Development. He is responsible for the execution of BioMarin’s discovery research programs, helping to shape the vision and long-term growth of our company through the oversight of an exceptional research pipeline of first- or best-in-class therapies. Learn more about Kevin here: w...

0:59

Meet Stephen Zoog

Переглядів 215Рік тому

Stephen Zoog, Ph.D., joined BioMarin in 2012 and serves as Vice President of Translational Sciences & Center of Technology. In this role, Dr. Zoog leads the strategy and transition of BioMarin’s lead candidates from research into early development and through registration for programs in rare genetic diseases. He oversees six departments focused on non-clinical pharmacology/toxicology, clinical...

0:51

Meet Hank Fuchs

Переглядів 319Рік тому

Henry J. Fuchs, M.D., joined BioMarin in March 2009 and currently serves as our President of Worldwide Research & Development. From December 2009 to October 2016, Dr. Fuchs served as our Executive Vice President and Chief Medical Officer. From March 2009 to December 2009, Dr. Fuchs served as our Senior Vice President and Chief Medical Officer. Learn more about Hank here: www.biomarin.com/our-co...

0:55

Meet Ganesh Vedantham

Переглядів 189Рік тому

Dr. Vedantham joined BioMarin in 2021. He is a seasoned leader in the biopharmaceutical industry, with global experience in various chemistry, manufacturing, and controls (CMC) functions across R&D and Technical Operations. Learn more about Ganesh here: www.biomarin.com/our-science/our-scientists/ganesh-vedantham/

1:00

Meet Gordon Vehar

Переглядів 174Рік тому

Gordon Vehar, Ph.D., joined BioMarin in January 2008 and currently serves as Vice President of External Innovation. In this role, he is responsible for the identification, evaluation and oversight of externally funded early research programs and the facilitation of decisions on eventual in-licensing. Learn more about Gordon here: www.biomarin.com/our-science/our-scientists/gordon-vehar-phd/

1:02

Meet Greg Guyer

Переглядів 243Рік тому

Greg Guyer, Ph.D, joined BioMarin in May 2020 and currently serves as our Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations, responsible for overseeing our manufacturing, process development, quality, supply chain, engineering and analytical chemistry departments.

3:00

Our Purpose

Переглядів 393Рік тому

We transform lives through genetic discovery. At BioMarin, through our unparalleled expertise in genetics and molecular biology, we will continue to develop targeted therapies that address the root cause of the conditions we seek to treat. Applying our knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most.

21:23

Free To Be Me

Переглядів 511Рік тому

BioMarin’s new original documentary-film Free To Be Me features a range of individuals from across Europe and poses the question, ‘what makes you, you?’ Watch Riccardo, Anna, Sandy and Claudia discuss their experiences and how their personal journeys and individual choices have shaped their identities, while living with a rare condition or disability. #freetobeme

2:41

BioMarin’s Gene Therapy Research

Переглядів 1,2 тис.Рік тому

BioMarin has a dedicated and professional approach to researching and understanding the potential of gene therapy. This video details how hard our team works to continue the advancement of gene therapy research for rare diseases. BioMarin is a global biotechnology company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live wi...

5:56

2022 Love Lock Ceremony

Переглядів 5052 роки тому

When it comes to commitment to patients, BioMarin has a lock on it. Each Rare Disease Day, we recognize people impacted by a rare genetic disease, as well as advocates and physicians, by placing a heart-shaped lock in their name on our “Trees of Life” sculpture. The sculpture and this annual ceremony were inspired by MPS advocate, Isabel Bueso, and they symbolize the deep relationship we have w...

7:20

Bone Growth in Achondroplasia

Переглядів 15 тис.2 роки тому

Achondroplasia, the most common cause of short stature, or dwarfism, affects nearly all of the bones in the body. As a result, on average people with achondroplasia are around 25% shorter than people of average height. Watch more to learn how bones grow and understand why achondroplasia impairs bone growth. BioMarin is a global biotechnology company focused on developing first-in-class therapeu...

2:43:52

BioMarin Virtual R&D Day 2021

Переглядів 2,6 тис.2 роки тому

BioMarin Pharmaceutical Inc., the global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare diseases and medical conditions, presents R&D Day 2021. The event provides an overview of BioMarin’s next-generation pipeline of development candidates that span a range of indications.